Maurice Zauderer - 08 Feb 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Scott E. Royer, Attorney-in-Fact Maurice Zauderer
Issuer symbol
VCNX
Transactions as of
08 Feb 2024
Transactions value $
$600,000
Form type
4
Filing time
09 Feb 2024, 16:34:03 UTC
Previous filing
03 Nov 2023
Next filing
22 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCNX Common Stock Award $300K +414K +42.24% $0.73 1.39M 08 Feb 2024 By Vaccinex (Rochester), L.L.C. F2
holding VCNX Common Stock 22.1K 08 Feb 2024 Direct
holding VCNX Common Stock 14.2K 08 Feb 2024 By Jeremy C. Zauderer Trust F1
holding VCNX Common Stock 14.1K 08 Feb 2024 By Jordan M. Zauderer Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Warrant (Right to Buy) Award $300K +414K $0.73 414K 08 Feb 2024 Common Stock 414K $1.00 By Vaccinex (Rochester), L.L.C. F2
holding VCNX Warrant (Right to Buy) 137K 08 Feb 2024 Common Stock 137K $2.34 By Vaccinex (Rochester), L.L.C. F2
holding VCNX Warrant (Right to Buy) 500K 08 Feb 2024 Common Stock 500K $1.00 By Vaccinex (Rochester), L.L.C. F2
holding VCNX Stock Option (Right to Buy) 172 08 Feb 2024 Common Stock 172 $223.50 Direct F3
holding VCNX Stock Option (Right to Buy) 172 08 Feb 2024 Common Stock 172 $223.50 Direct F3
holding VCNX Stock Option (Right to Buy) 221 08 Feb 2024 Common Stock 221 $106.50 Direct F3
holding VCNX Stock Option (Right to Buy) 1.33K 08 Feb 2024 Common Stock 1.33K $64.35 Direct F3
holding VCNX Stock Option (Right to Buy) 1.89K 08 Feb 2024 Common Stock 1.89K $100.20 Direct F4
holding VCNX Stock Option (Right to Buy) 933 08 Feb 2024 Common Stock 933 $43.95 Direct F5
holding VCNX Stock Option (Right to Buy) 1.87K 08 Feb 2024 Common Stock 1.87K $19.35 Direct F6
holding VCNX Stock Option (Right to Buy) 3.73K 08 Feb 2024 Common Stock 3.73K $6.59 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
F2 Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Exercisable in full as of the date of this report.
F4 This option vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date, except as otherwise provided in the award notice.
F5 This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
F6 This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
F7 This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.